Premium
Malignant potential of oral and labial chronic discoid lupus erythematosus: a clinicopathological study of 87 cases
Author(s) -
Liu Wei,
Shen ZhengYu,
Wang LiJia,
Hu YuHua,
Shen XueMing,
Zhou ZengTong,
Li Jiang
Publication year - 2011
Publication title -
histopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.626
H-Index - 124
eISSN - 1365-2559
pISSN - 0309-0167
DOI - 10.1111/j.1365-2559.2011.03934.x
Subject(s) - medicine , discoid lupus erythematosus , malignant transformation , dysplasia , univariate analysis , histopathology , confidence interval , risk factor , lupus erythematosus , gastroenterology , dermatology , multivariate analysis , pathology , immunology , antibody
Liu W, Shen Z‐Y, Wang L‐J, Hu Y‐H, Shen X‐M, Zhou Z‐T & Li J
(2011) Histopathology 59 , 292–298 Malignant potential of oral and labial chronic discoid lupus erythematosus: a clinicopathological study of 87 cases Aims: To investigate clinicopathological features and identify clinicopathological risk factors for the malignant transformation of oral and labial chronic discoid lupus erythematosus (DLE) in a relatively large number of patients from China. Methods and results: A total of 87 patients with clinical and histopathological diagnosis of DLE between 1993 and 2009 were reviewed retrospectively in our hospital. The average age at diagnosis was 51.7 years, with a male:female ratio of 1:1.8. The lower lip was the most common site (71.3%). We documented six DLE patients with malignant transformation. On univariate analysis, patients with high‐risk dysplasia ( P = 0.002) or aged >60 ( P = 0.045) were associated with DLE malignant transformation, but gender, lesion site, smoking and alcohol intake were not risk factors. On multivariate analysis, high‐risk dysplasia was a significant indicator for DLE malignant transformation. High‐risk dysplasia was associated with a 14.24‐fold [95% confidence interval (95% CI), 1.97–102.88; P = 0.008] increased risk of malignant transformation, compared with non/low‐risk dysplasia. Conclusions: The utilization of high‐risk dysplasia as a significant indicator for evaluating malignant transformation risk in patients with DLE is suggested, which may be helpful to guide treatment selection.